Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00392652 · ClinicalTrials.gov registry record · Phase 1
Diindolylmethane in Healthy Volunteers
A Phase 1 study of Healthy, no Evidence of Disease, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- Phase 1
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT00392652 is a Phase 1 study of Healthy, no Evidence of Disease that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 14 participants, below the 176-participant average among 11 other Healthy, no Evidence of Disease trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00392652, a Phase 1 study of Healthy, no Evidence of Disease, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized phase I trial is studying the side effects and best dose of diindolylmethane in healthy volunteers. Chemoprevention is the use of certain drugs or substances to keep cancer from forming, growing, or coming back. The use of diindolylmethane may keep cancer from forming. Collecting and storing samples of blood and urine from healthy volunteers to study in the laboratory may help doctors learn more about the way a person's body handles the drug.
Conditions Studied
Interventions
- DRUG oral microencapsulated diindolylmethane
Study Locations (1)
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2006-11 |
| Est. Completion | 2009-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00392652
The ClinicalTrials.gov registry entry for NCT00392652 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 176-participant average among 11 other Healthy, no Evidence of Disease trials with a reported enrollment target (92% lower). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy, no Evidence of Disease appearing as the primary indexed condition, and to 1 intervention - of which oral microencapsulated diindolylmethane is the first listed.
NCT00392652 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.
Frequently Asked Questions
What is clinical trial NCT00392652 about?
NCT00392652 is a clinical study titled "Diindolylmethane in Healthy Volunteers". This randomized phase I trial is studying the side effects and best dose of diindolylmethane in healthy volunteers. Chemoprevention is the use of certain drugs or substances to keep cancer from forming, growing, or coming back. The use of diindolylmethane may keep cancer from forming. Collecting and...
What is the current status of trial NCT00392652?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2006-11. Estimated completion is 2009-10.
What conditions does trial NCT00392652 study?
This clinical trial studies the following conditions: Healthy, no Evidence of Disease.
What interventions are being tested in trial NCT00392652?
The interventions under investigation include: oral microencapsulated diindolylmethane (DRUG).
Who is sponsoring clinical trial NCT00392652?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00392652 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy, no Evidence of Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Studying Different Formulations of SR13668 in Healthy Volunteers
COMPLETED · Phase 1
-
Linaclotide Acetate in Preventing Colorectal Cancer in Healthy Volunteers
COMPLETED · Phase 1
-
Se-Methyl-Seleno-L- Cysteine (MSC) in Treating Healthy Patients
COMPLETED · Phase 1
-
Lycopene in Healthy Male Participants
COMPLETED · Phase 1
-
Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer
COMPLETED · Phase 1
-
A Nutritional Supplement Capsule Containing Curcumin, Green Tea Extract, Polygonum Cuspidatum Extract, and Soybean Extract in Healthy Participants
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.